07.08.2018 • NewsBioAmberElaine Burridge

BioAmber Seeks to Liquidate Assets

BioAmber Seeks to Liquidate Assets (c) Erce/Shutterstock
BioAmber Seeks to Liquidate Assets (c) Erce/Shutterstock

Having received no acceptable offers for its business by a Jul. 27 deadline, Canadian renewable chemicals company BioAmber is now seeking court approval to liquidate its assets, which include a commercial scale succinic acid plant in Sarnia, Ontario, Canada.

The company filed for bankruptcy protection in the US and Canada in May.

“We are clearly disappointed that the qualified bidders did not place an acceptable offer for BioAmber,” said CEO Richard Eno. “We will continue to be actively engaged with potential investors to seek an acceptable transaction and avoid the liquidation of the company’s assets.” The company has until Aug. 14 to conclude a transaction.

Last year, two class action lawsuits were filed in the US against BioAmber by investors claiming that the company made false and misleading statements between Dec. 23, 2016 and Mar. 16, 2017. The claimants allege it failed to disclose that an expected $2.8 million sale of succinic acid was postponed from the fourth quarter of 2016 to sometime in 2017, causing the value of their shares to drop once the news became public.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.